
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Red clover contains isoflavones including genistein and daidzein that function as phytoestrogens, binding to estrogen receptors to provide mild estrogenic activity. These compounds may help reduce menopausal symptoms and support bone health through selective estrogen receptor modulation.

Reported Benefits (Provisional)
Origin & History

Red Clover, derived from the flowers of the Trifolium pratense plant, is native to Europe and Asia. The flowers are harvested and processed for their isoflavones, which are used for hormonal health.
Research Narrative (Provisional)
Some RCTs suggest Red Clover may help reduce menopause symptoms, though results are mixed. More research is needed for conclusive evidence.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in isoflavones, which support hormonal health. - Contains flavonoids with antioxidant effects. - Provides coumarins that support cardiovascular health.
Reported Mechanism (Provisional)
Red clover's primary bioactive compounds are isoflavones including genistein, daidzein, biochanin A, and formononetin, which act as selective estrogen receptor modulators (SERMs). These phytoestrogens bind to both ERα and ERβ estrogen receptors with higher affinity for ERβ, providing tissue-selective estrogenic or anti-estrogenic effects. The compounds also influence bone metabolism by stimulating osteoblast activity and inhibiting osteoclast formation through the RANK/RANKL pathway.
Clinical Narrative (Provisional)
Multiple randomized controlled trials with 30-252 participants have shown red clover extracts (40-80mg daily) may reduce menopausal hot flashes by 20-44% compared to placebo over 12-16 weeks. Studies on bone health show mixed results, with some trials demonstrating 4-6% increases in bone mineral density at the spine and hip after 12 months of supplementation. However, several systematic reviews note significant heterogeneity in study designs and call for larger, longer-duration trials to confirm cardiovascular and bone benefits.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







